Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia (ALL)

More than 400 clinical trials are currently accepting participants diagnosed with Acute Lymphoblastic Leukemia (ALL).

Acute Lymphoblastic Leukaemia (ALL) is a form of blood cancer originating from white blood cells known as lymphocytes within the bone marrow. The bone marrow, the spongy tissue inside bones, is responsible for the creation of new blood cells. This disease typically progresses rapidly, often within days or weeks. It is predominantly seen in children, making it the most prevalent type of leukaemia in this demographic, though adults can also be affected.

What clinical trials are

Learn more

Before you take part in a clinical trial

Learn more

Find the right clinical trial

Learn more